ILMN Key Stats
|Revenue (Quarterly YoY Growth)||24.81%|
|EPS Diluted (TTM)||0.8311|
|EPS Diluted (Quarterly YoY Growth)||0.00%|
|Net Income (TTM)||116.55M|
|Gross Profit Margin (Quarterly)||58.84%|
|Profit Margin (Quarterly)||8.79%|
|Dividend Yield (TTM)||0%|
|Payout Ratio (TTM) Pro||Go Pro|
- Fundamentally Attractive Biotechnology "Pick & Shovel" Companies Dec 5
- Illumina's Management Presents at Piper Jaffray 25th Annual Healthcare Conference (Transcript) Seeking Alpha Dec 3
- Insider Trading Alert - BEAV, DLR, ILMN, CHS And MTOR Traded By Insiders The Street Dec 3
- Illumina Inc. (ILMN): Today's Featured Health Care Winner The Street Nov 27
- New Lifetime High Reached By Illumina (ILMN) Nov 25
- Illumina (ILMN) Marked As A Barbarian At The Gate Nov 21
- FDA Go-Ahead for Illumina's Offerings Nov 20
- FDA Go-Ahead for Illumina's Offerings - Analyst Blog Zacks Nov 20
- Illumina’s MiSeqDxTM Receives FDA Premarket Clearance with Two Cystic Fibrosis Assays and Universal Kit for Open Use noodls Nov 19
- Illumina's MiSeqDx system receives FDA premarket clearance Nov 19
ILMN Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Illumina is up 95.34% over the last year vs S&P 500 Total Return up 30.68%, Actelion up 64.18%, and Life Technologies up 52.26%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for ILMN
Pro Report PDF for ILMN
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download ILMN Pro Report PDF
Pro Strategies Featuring ILMN
Did Illumina make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Illumina, Inc. is developer, manufacturer and marketer of integrated systems for the large scale analysis of genetic variation and biological function.